Roche ($RHHBY) and AstraZeneca ($AZN) picked up FDA breakthrough therapy designations for their top pipeline assets, moving forward in multiple sclerosis and cancer with treatments tabbed as potential blockbusters.
{iframe}http://www.fiercebiotech.com/story/roche-and-astrazeneca-snag-breakthrough-tags-pair-blockbusters-waiting/2016-02-17{/iframe}